US010280398B2 (12 ) United States Patent ( 10 ) Patent No. : US 10 ,280 , 398 B2 Studer et al. (45 ) Date of Patent: May 7 , 2019 ( 54 ) MIDBRAIN DOPAMINE (DA ) NEURONS FOR 5 ,523 , 226 A 6 / 1996 Wheeler ENGRAFTMENT 5 , 589 , 376 A 12 / 1996 Anderson et al . 6 ,610 , 540 B1 8 / 2003 Csete et al . 6 ,787 , 356 B1 9 /2004 Studer et al . (71 ) Applicant: MEMORIAL SLOAN -KETTERING 6 ,833 ,269 B2 12 /2004 Carpenter CANCER CENTER , New York , NY 6 , 887 , 706 B2 5 /2005 Zhang et al . (US ) 7 , 005 , 252 B1 2 / 2006 Thomson 7 ,011 , 828 B2 3 /2006 Reubinoff et al . 7 , 112 ,437 B2 9 / 2006 Pera ( 72 ) Inventors : Lorenz Studer , New York , NY (US ) ; 7 , 211 , 434 B2 5 / 2007 Van Der Kooy et al. Jae - Won Shim , New York , NY (US ) ; 7 , 252 , 995 B2 8 / 2007 Fu et al. Sonja Kriks , New York , NY (US ) 7 , 294 , 510 B2 11/ 2007 Okano et al. 7 ,297 , 539 B2 11/ 2007 Mandalam et al. (73 ) Assignee : MEMORIAL SLOAN -KETTERING (Continued ) CANCER CENTER , New York , NY (US ) FOREIGN PATENT DOCUMENTS ( * ) Notice : Subject to any disclaimer, the term of this CA 2923592 A1 3 /2015 CN 102191221 A 9 / 2011 patent is extended or adjusted under 35 EP 1 645 286 A1 4 /2006 U . S . C . 154 (b ) by 0 days . KR 101331034 B1 11/ 2013 ( 21) Appl . No. : 14 /356 , 042 (Continued ) ( 22 ) PCT Filed : Nov . 2 , 2012 OTHER PUBLICATIONS ( 86 ) PCT No. : PCT/ US2012 / 063339 MacDonald (2009 , Developmental Cell, 17 : 9 - 26 ). * Katoh , Cancer Biology and Therapy, 2006 , 5 : 1059 - 1064 . * $ 371 ( c ) ( 1 ), Gordon , 2006 , Journal of Biological Chemistry , 281: 22429 - 22433 . * ( 2 ) Date : May 2 , 2014 Willert , CSH Perspectives in Biology , 2012 , 4 : 1 - 13 . * Wang , Stem Cells and Development , 2010 , 19 : 1375 - 1383. * ( 87 ) PCT Pub . No. : W02013 / 067362 Thomson et al. (PNAS , 92: 7844 - 7848 ( Aug. 1995 ) ). * NIH ( Stem Cells : Scientific Progress and Future Research Direc PCT Pub . Date : May 10 , 2013 tions , Department of Health and Human Services, Chapter 1 , pp . (65 ) Prior Publication Data 1 - 4 , Jun . 2001 ) . * US 2015 /0010514 A1 Jan . 8 , 2015 (Continued ) Primary Examiner — Valarie E Bertoglio Related U . S . Application Data ( 74) Attorney , Agent, or Firm — Baker Botts L .L .P . (60 ) Provisional application No . 61/ 555, 828 , filed on Nov. 4 , 2011 . ( 57 ) ABSTRACT The present invention relates to the field of stem cell (51 ) Int. Cl. biology , in particular the lineage specific differentiation of C12N 5 / 02 ( 2006 . 01 ) pluripotent or multipotent stem cells , which can include , but C12N 5 / 00 ( 2006 . 01) is not limited to , human embryonic stem cells (hESC ) in C12N 5 /0793 ( 2010 .01 ) addition to nonembryonic human induced pluripotent stem A61K 35 / 30 ( 2015 . 01 ) cells (hiPSC ) , somatic stem cells , stem cells from patients C12N 5 /0797 (2010 . 01) with a disease , or any other cell capable of lineage specific ( 52 ) U . S . CI. differentiation . Specifically described are methods to direct CPC . .. .. .. .. C12N 5 /0619 ( 2013 . 01 ) ; A61K 35 / 30 the lineage specific differentiation of hESC and/ or hiPSC ( 2013 . 01 ) ; CI2N 5 / 0623 ( 2013 .01 ) ; C12N into floor plate midbrain progenitor cells and then further 2501 /01 ( 2013 . 01 ) ; C12N 2501 / 119 (2013 .01 ) ; into large populations of midbrain fate FOXA2 + LMX1A + C12N 2501 / 13 (2013 .01 ) ; C12N 2501/ 15 TH + dopamine (DA ) neurons using novel culture condi ( 2013 .01 ) ; C12N 2501 / 16 ( 2013 . 01 ) ; C12N tions . The midbrain fate FOXA2 + LMX1A + TH + dopamine 2501 /41 (2013 . 01 ) ; C12N 2501 /415 ( 2013 .01 ) ; (DA ) neurons made using the methods of the present inven C12N 2501/ 999 ( 2013 .01 ) ; CI2N 2506 /02 tion are further contemplated for various uses including , but ( 2013 .01 ) ; C12N 2506 /45 ( 2013 .01 ) not limited to , use in in vitro drug discovery assays , neu (58 ) Field of Classification Search rology research , and as a therapeutic to reverse disease of, or CPC . .. .. C12N 5 /0619 damage to , a lack of dopamine neurons in a patient. Further, See application file for complete search history . compositions and methods are provided for differentiating midbrain fate FOXA2 + LMX1A + TH + dopamine (DA ) neu ( 56 ) References Cited rons from human pluripotent stem cells for use in disease modeling , in particular Parkinson ' s disease . Additionally , U . S . PATENT DOCUMENTS authentic DA neurons are enriched for markers , such as 5 , 166 , 065 A 11/ 1992 Williams et al. CD142 , and A9 type neuronal cells . 5 , 340 ,740 A 8 / 1994 Petitte et al . 5 ,453 , 357 A 9 / 1995 Hogan 14 Claims, 35 Drawing Sheets US 10 ,280 , 398 B2 Page 2 (56 ) References Cited Chambers , S . M . et al ., “ Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling ” , U . S . PATENT DOCUMENTS Nature Biotechnology, vol. 27 , No . 3 , Mar. 1 , 2009 , pp . 275 - 280 . Cooper , O . et al. , “ Differentiation of human ES and Parkinson ' s 7 , 332 , 336 B2 2 / 2008 Ochiya et al. 7 , 368 , 115 B2 5 / 2008 Ohta et al. disease iPS cells into ventralmidbrain dopaminergic neurons requires 7 , 763 , 463 B2 7 / 2010 Carpenter et al. a high activity form of SHH , FGF8a and specific regionalization by 7 , 892, 830 B2 2 / 2011 Bergendahl et al. retinoic acid ” , Molecular and Cellular Neurosciences , vol. 45 , No. 8 , 153 ,422 B2 4 / 2012 Isacson et al. 3 , Nov. 1 , 2010 , pp . 258 - 266 . 8 , 153 , 428 B2 4 /2012 Carpenter et al . Fasano , C . A . et al. , Efficient Derivation of Functional Floor Plate 8 , 252 , 585 B2 8 / 2012 Carpenter Tissue from Human Embryonic Stem Cells , Cell Stem Cell, Apr. 2 , 8 , 252 , 586 B2 8 / 2012 Carpenter et al . 8 ,323 ,971 B2 12 / 2012 Pedersen et al . 2010 , vol. 6 , No. 4 , pp . 336 -347 . 8 ,551 ,783 B2 10 / 2013 Kim et al. Joksimovic , M . et al . , “ Wnt antagonism of Shh facilitates midbrain 8 ,642 , 334 B2 2 / 2014 Chambers et al . floor plate neurogenesis ” , Developmental Biology , vol. 331 , No . 2 , 8 , 883 , 502 B2 11 / 2014 Zhang et al. Jul. 15, 2009 , pp . 507 -508 . 8 , 932 , 857 B2 1 / 2015 Yamanaka et al . Kriks, S . et al ., Dopamine neurons derived from human ES cells 9 ,249 , 389 B2 2 / 2016 Isacson et al. efficiently engraft in animal models of Parkinson ' s disease , Nature , 9 , 453 , 198 B2 9 / 2016 Studer et al . Nov . 6 , 2011 , vol . 480 , No. 7378 , pp . 547 -551 . 9 , 487 ,751 B2 11 / 2016 Anderson et al. Extended European Search Report dated Mar. 10 , 2015 issued in 2003 / 0036195 AL 2 / 2003 Studer et al . 2003/ 0211605 AL 11/ 2003 Lee et al. European Patent Application No. 12846715 . 6 . 2004 / 0005704 AL 1 / 2004 Csete et al. International Search Report dated Mar. 29 , 2013 in International 2004 /0087478 AL 5 / 2004 Gillen et al . Patent Application No. PCT/ US2012 /063339 . 2004 /0214324 Al 10 / 2004 Isacson et al . Written Opinion of the International Searching Authority dated Mar. 2005 /0260747 AL 11/ 2005 Reubinoff et al. 29 , 2013 in International Patent Application No . PCT /US2012 / 2006 /0078543 A1 4 / 2006 Reubinoff et al . 063339 2007 / 0224650 A1 9 / 2007 Jessell et al. Chambers et al. , “ Combined small -molecule inhibition accelerates 2009 /0035285 Al 2 / 2009 Condie et al. developmental timing and converts human pluripotent stem cells 2010 / 0009442 A1 1 / 2010 Sasai et al . into nociceptors, ” 2012 , Nature Biotechnology 30 ( 7 ) :715 - 720 . 2010 / 0093090 A1 4 / 2010 Deng et al. Crawford et al ., “ The Notch Response Inhibitor DAPT Enhances 2010 /0099772 A1 4 / 2010 Bean et al . Neuronal Differentiation in Embryonic Stem Cell - Derived Embryoid 2011/ 0229441 A1 9 / 2011 Benchoua et al. 2012 /0094381 A1 4 / 2012 Chambers et al. Bodies Independently of Sonic Hedgehog Signaling, " 2007 , Devel 2012 / 0142093 A1 6 / 2012 Takahashi et al. opmental Dynamics 236 : 886 - 892 . 2012 / 0148549 A1 6 / 2012 Anderson et al. Kirkeby et al. , “ Predictive Markers Guide Differentiation to Improve 2012/ 0322146 Al 12/ 2012 Carpenter et al . Graft Outcome in Clinical Translation of hESC Based Therapy for 2013 /0108669 Al 5 / 2013 Cooper et al. Parkinson ' s Disease , " Cell Stem Cell , available online Oct . 27 , 2013 / 0183674 AL 7 / 2013 Studer et al . 2016 ( 2016 ) , downloaded Feb . 2 , 2017 from < http : // dx . doi. org / 10 . 2014 /0199274 Al 7 / 2014 Kim et al. 1016 / j. stem / 2016 .09 . 004 > . 2014 / 0248696 A1 9 / 2014 Zhang et al. Li et al . , “ Rapid induction and long - term self- renewal of primitive 2014 / 0314721 Al 10 / 2014 Semechkin et al . neural precursors from human embryonic stem cells by small 2015 / 0010514 Al 1 / 2015 Studer et al. molecule inhibitors , " 2011 , PNAS 108 ( 20 ) : 8299 - 8304 . 2015 / 0010515 A1 1 / 2015 Schoeler et al . 2015 /0030570 A1 1 / 2015 Pan et al . Placantonakis et al. , “ BAC Transgenesis in Human Embryonic Stem 2015 / 0086481 Al 3 / 2015 Ganat et al . Cells as a Novel Tool to Define the Human Neural Lineage , ” 2009 , 2015 / 0087541 Al 3 / 2015 Gonzalez et al. Stem Cells 27 : 521 -532 . 2015 /0265652 A1 9 / 2015 George et al . Raymon et al ., “ Immortalized Human Dorsal Root Ganglion Cells 2015 /0353888 A1 12 / 2015 Inoue et al . Differentiate into Neurons with Nociceptive Properties, ” 1999 , J . 2016 /0108362 A1 4 / 2016 Su et al. Neurosci. 19 ( 13 ) : 5420 - 5428. 2016 /0115444 Al 4 / 2016 Studer et al. Steinbeck et al . , " Optogenetics enables functional analysis of human 2016 /0115448 A1 4 / 2016 Studer et al . embryonic stem cell -derived grafts in a Parkinson ' s disease model, ” 2016 /0145582 A1 5 / 2016 Yu 2015 , Nature Biotechnology 33 ( 2 ) : 204 - 209 . 2016 / 0201032 A1 7 / 2016 Studer et al .